A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19
2022-06-27
عنوان الدراسة
A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19
داعم الدراسة
GDRS (MOH)
دواء الدراسة
Convalescent Plasma
رقم بروتوكول الدراسة
20-COVID-19-01M
حالة الدراسة
Ongoing
موقع الدراسة
KFSH-D
مرحلة الدراسة
2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。